• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用计算技术更新和探索 CBP [环磷酸腺苷反应元件结合蛋白(CREB)结合蛋白] 研究的潜在机会。

Update and Potential Opportunities in CBP [Cyclic Adenosine Monophosphate (cAMP) Response Element-Binding Protein (CREB)-Binding Protein] Research Using Computational Techniques.

机构信息

Molecular Bio-computation and Drug Design Laboratory, School of Health Sciences, University of KwaZulu-Natal, Westville Campus, Durban, 4001, South Africa.

出版信息

Protein J. 2021 Feb;40(1):19-27. doi: 10.1007/s10930-020-09951-8. Epub 2021 Jan 4.

DOI:10.1007/s10930-020-09951-8
PMID:33394237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7868315/
Abstract

CBP [cyclic adenosine monophosphate (cAMP) response element-binding protein (CREB)-binding protein] is one of the most researched proteins for its therapeutic function. Several studies have identified its vast functions and interactions with other transcription factors to initiate cellular signals of survival. In cancer and other diseases such as Alzheimer's, Rubinstein-taybi syndrome, and inflammatory diseases, CBP has been implicated and hence an attractive target in drug design and development. In this review, we explore the various computational techniques that have been used in CBP research, furthermore we identified computational gaps that could be explored to facilitate the development of highly therapeutic CBP inhibitors.

摘要

CBP(环磷酸腺苷反应元件结合蛋白-结合蛋白)是研究最多的具有治疗功能的蛋白质之一。多项研究已经确定了其广泛的功能以及与其他转录因子的相互作用,以启动细胞存活信号。在癌症和其他疾病(如阿尔茨海默病、鲁宾斯坦-泰比综合征和炎症性疾病)中,CBP 已被牵涉在内,因此成为药物设计和开发的有吸引力的靶标。在这篇综述中,我们探讨了在 CBP 研究中使用的各种计算技术,此外还确定了可以探索的计算空白,以促进高度治疗性 CBP 抑制剂的开发。

相似文献

1
Update and Potential Opportunities in CBP [Cyclic Adenosine Monophosphate (cAMP) Response Element-Binding Protein (CREB)-Binding Protein] Research Using Computational Techniques.利用计算技术更新和探索 CBP [环磷酸腺苷反应元件结合蛋白(CREB)结合蛋白] 研究的潜在机会。
Protein J. 2021 Feb;40(1):19-27. doi: 10.1007/s10930-020-09951-8. Epub 2021 Jan 4.
2
Rubinstein-Taybi syndrome: molecular findings and therapeutic approaches to improve cognitive dysfunction.鲁宾斯坦-泰比综合征:改善认知功能障碍的分子研究结果及治疗方法
Cell Mol Life Sci. 2006 Aug;63(15):1725-35. doi: 10.1007/s00018-005-5555-8.
3
Administration of BMP2/7 in utero partially reverses Rubinstein-Taybi syndrome-like skeletal defects induced by Pdk1 or Cbp mutations in mice.宫内给予 BMP2/7 可部分逆转 Pdk1 或 Cbp 基因突变诱导的小鼠 Rubinstein-Taybi 综合征样骨骼缺陷。
J Clin Invest. 2012 Jan;122(1):91-106. doi: 10.1172/JCI59466. Epub 2011 Dec 1.
4
A mouse model of Rubinstein-Taybi syndrome: defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4.鲁宾斯坦-泰比综合征的小鼠模型:磷酸二酯酶4抑制剂可改善长期记忆缺陷。
Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10518-22. doi: 10.1073/pnas.1834280100. Epub 2003 Aug 20.
5
Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome.鲁宾斯坦-泰比综合征中核转录共激活因子CBP的组蛋白乙酰转移酶活性缺陷。
Hum Mol Genet. 2001 May 1;10(10):1071-6. doi: 10.1093/hmg/10.10.1071.
6
The transcriptional coactivator and histone acetyltransferase CBP regulates neural precursor cell development and migration.转录共激活因子和组蛋白乙酰转移酶 CBP 调节神经前体细胞的发育和迁移。
Acta Neuropathol Commun. 2019 Dec 5;7(1):199. doi: 10.1186/s40478-019-0849-5.
7
Temporal recruitment of transcription factors at the 3',5'-cyclic adenosine 5'-monophosphate-response element of the human GnRH-II promoter.转录因子在人促性腺激素释放激素-II启动子的3',5'-环磷酸腺苷反应元件处的瞬时募集。
Endocrinology. 2008 Oct;149(10):5162-71. doi: 10.1210/en.2008-0481. Epub 2008 Jul 3.
8
Rubinstein-Taybi syndrome: clinical and molecular overview.鲁宾斯坦-泰比综合征:临床与分子概述
Expert Rev Mol Med. 2007 Aug 20;9(23):1-16. doi: 10.1017/S1462399407000415.
9
SAR optimization studies on modified salicylamides as a potential treatment for acute myeloid leukemia through inhibition of the CREB pathway.通过抑制 CREB 通路,对作为急性髓性白血病潜在治疗方法的改性水杨酰胺进行 SAR 优化研究。
Bioorg Med Chem Lett. 2019 Aug 15;29(16):2307-2315. doi: 10.1016/j.bmcl.2019.06.023. Epub 2019 Jun 19.
10
Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism.截短的CBP蛋白在小鼠中导致典型的鲁宾斯坦-泰比综合征表型:对显性负性机制的启示。
Hum Mol Genet. 1999 Mar;8(3):387-96. doi: 10.1093/hmg/8.3.387.

引用本文的文献

1
Cellular stress and epigenetic regulation in adult stem cells.成体干细胞中的细胞应激与表观遗传调控。
Life Sci Alliance. 2024 Sep 30;7(12). doi: 10.26508/lsa.202302083. Print 2024 Dec.
2
Functional analysis of a novel pathogenic variant in CREBBP associated with bone development.与骨骼发育相关的CREBBP基因新型致病变异的功能分析
Pediatr Res. 2024 Dec;96(7):1626-1635. doi: 10.1038/s41390-024-03490-z. Epub 2024 Aug 31.
3
Multi-faceted regulation of CREB family transcription factors.CREB家族转录因子的多方面调控

本文引用的文献

1
Exploring the Role of Asp1116 in Selective Drug Targeting of CREBcAMP- Responsive Element-binding Protein Implicated in Prostate Cancer.探讨 CREB/cAMP 反应元件结合蛋白中 Asp1116 残基在前列腺癌选择性药物靶向治疗中的作用。
Comb Chem High Throughput Screen. 2020;23(3):178-184. doi: 10.2174/1386207323666200219122057.
2
The novel BET-CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer.新型 BET-CBP/p300 双重抑制剂 NEO2734 对 SPOP 突变型和野生型前列腺癌均具有活性。
EMBO Mol Med. 2019 Nov 7;11(11):e10659. doi: 10.15252/emmm.201910659. Epub 2019 Sep 26.
3
Discovery of novel CBP bromodomain inhibitors through TR-FRET-based high-throughput screening.
Front Mol Neurosci. 2024 Aug 6;17:1408949. doi: 10.3389/fnmol.2024.1408949. eCollection 2024.
4
Investigating the Relevance of Cyclic Adenosine Monophosphate Response Element-Binding Protein to the Wound Healing Process: An In Vivo Study Using Photobiomodulation Treatment.研究环磷酸腺苷反应元件结合蛋白与创伤愈合过程的相关性:应用光生物调节治疗的体内研究。
Int J Mol Sci. 2024 Apr 29;25(9):4838. doi: 10.3390/ijms25094838.
5
Protective effect of Blume in a Caenorhabditis elegans model of Alzheimer's disease based on network pharmacology.基于网络药理学的白梅花在秀丽隐杆线虫阿尔茨海默病模型中的保护作用
Biomed Rep. 2023 Apr 12;18(5):37. doi: 10.3892/br.2023.1620. eCollection 2023 May.
通过基于时间分辨荧光共振能量转移的高通量筛选发现新型 CBP 溴结构域抑制剂。
Acta Pharmacol Sin. 2020 Feb;41(2):286-292. doi: 10.1038/s41401-019-0256-2. Epub 2019 Jun 28.
4
Y08197 is a novel and selective CBP/EP300 bromodomain inhibitor for the treatment of prostate cancer.Y08197 是一种新型、选择性的 CBP/EP300 溴结构域抑制剂,用于治疗前列腺癌。
Acta Pharmacol Sin. 2019 Nov;40(11):1436-1447. doi: 10.1038/s41401-019-0237-5. Epub 2019 May 16.
5
Bromodomain Drug Discovery - the Past, the Present, and the Future.溴结构域药物发现——过去、现在和未来。
Chem Rec. 2018 Dec;18(12):1808-1817. doi: 10.1002/tcr.201800074. Epub 2018 Oct 5.
6
CBP/p300 inhibitor C646 prevents high glucose exposure induced neuroepithelial cell proliferation.CBP/p300 抑制剂 C646 可预防高糖暴露诱导的神经上皮细胞增殖。
Birth Defects Res. 2018 Aug 15;110(14):1118-1128. doi: 10.1002/bdr2.1360. Epub 2018 Aug 16.
7
Inhibitor of CBP Histone Acetyltransferase Downregulates p53 Activation and Facilitates Methylation at Lysine 27 on Histone H3.CBP 组蛋白乙酰转移酶抑制剂下调 p53 激活并促进组蛋白 H3 赖氨酸 27 的甲基化。
Molecules. 2018 Aug 2;23(8):1930. doi: 10.3390/molecules23081930.
8
Association study of CREB1 and CBP genes with Alzheimer's disease in Han Chinese.汉族人群中CREB1和CBP基因与阿尔茨海默病的关联研究
Asia Pac Psychiatry. 2017 Sep;9(3). doi: 10.1111/appy.12274.
9
Formation of neurodegenerative aggresome and death-inducing signaling complex in maternal diabetes-induced neural tube defects.母体糖尿病致神经管缺陷中神经退行性聚集物和诱导死亡信号复合物的形成。
Proc Natl Acad Sci U S A. 2017 Apr 25;114(17):4489-4494. doi: 10.1073/pnas.1616119114. Epub 2017 Apr 10.
10
Fragment-based in silico screening of bromodomain ligands.基于片段的溴结构域配体计算机模拟筛选
Drug Discov Today Technol. 2016 Mar;19:81-90. doi: 10.1016/j.ddtec.2016.06.003. Epub 2016 Jul 21.